Your browser doesn't support javascript.
loading
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
Arora, Shaily; Balasubramaniam, Sanjeeve; Zhang, Hui; Berman, Tara; Narayan, Preeti; Suzman, Daniel; Bloomquist, Erik; Tang, Shenghui; Gong, Yutao; Sridhara, Rajeshwari; Turcu, Francisca Reyes; Chatterjee, Deb; Saritas-Yildirim, Banu; Ghosh, Soma; Philip, Reena; Pathak, Anand; Gao, Jennifer J; Amiri-Kordestani, Laleh; Pazdur, Richard; Beaver, Julia A.
Afiliação
  • Arora S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Balasubramaniam S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Zhang H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Berman T; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Narayan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Suzman D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Bloomquist E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Gong Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Sridhara R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Turcu FR; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Chatterjee D; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Saritas-Yildirim B; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Ghosh S; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Philip R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pathak A; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Gao JJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Beaver JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Oncologist ; 26(1): e164-e172, 2021 01.
Article em En | MEDLINE | ID: mdl-33017510
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido